Biowebspin, May 30th, 2016 University-led Innovation Initiatives: Lessons from PRAI 2015 by Cara Griffin, Eugenie Birch and Laura Barro in Penn Institue for Urban Research, 2016 The Penn IUR Roundtable on Anchor Institutions (PRAI) is a leadership “think tank” that convenes executive- session meetings of high-level anchor institution leaders to explore innovative strategies in urban development.... »
Archives May 2016 - Biowebspin
Biowebspin, May 20th, 2016 Innovation Clusters: Advantages and Disadvantages by Vladimir V. Mazur, Karine A. Barmuta, Sergey S. Demin, Evgeny A. Tikhomirov, Maxsim A. Bykovskiy in International Journal of Economics and Financial Issues, 2016 The main direction of the current economic development is found in a transition of the most civilized countries to a new stage of creating an innovative soc... »
Biowebspin, May 16th, 2016 Collaboration in science and technology organizations of the public sector: A network perspective by Bruna PF Fonseca, Elton Fernandes and Marcus VA Fonseca, in Science and public policy, 2016 Engaging in collaborative networks can be an important facilitator of innovation for public sector science and technology (S&T) organizations. It is also an important component... »
Biowebspin, May 09th, 2016 The effects of university rules on spinoff creation: The case of academia in Italy by Alessandro Muscioa, Davide Quaglioneb, Laura Ramaciottic, in Research Policy, 2016 The economics literature provides rich evidence on the convergence between the institutional factors and individual-level characteristics influencing the involvement of academia in knowledge transfer ac... »
Competitive Advantage, Open Innovation, and Dynamic Capabilities: Is Sanofi Employing an Open Innovation Strategy?
Biowebspin, May 06th, 2016 Competitive Advantage, Open Innovation, and Dynamic Capabilities: Is Sanofi Employing an Open Innovation Strategy? by Geoffroy Labrouche and Med Kechidi, in Handbook of Research on Driving Competitive Advantage through Sustainable, Lean, and Disruptive Innovation, 2016 This chapter deals with a particular type of dynamic capability: dynamic relational capabilities. The... »
Biowebspin, May 2nd, 2016 Changing R&D models in research-based pharmaceutical companies by Alexander Schuhmacher, Oliver Gassmann, and Markus Hinder in J Transl Me, 2016 New drugs serving unmet medical needs are one of the key value drivers of research-based pharmaceutical companies. The efficiency of research and development (R&D), defined as the successful approval and launch of new m... »